INDEPENDENT, SCALABLE AND SPECIALIZED

Real-World Data for Precision Evidence

ConcertAI’s rich suite of independent real-world data products are fit-for-purpose to meet a variety of research and real-world evidence uses cases across the enterprise.

 
0+

EMR Systems

0%

Clinical-Open Claims Overlap

0+

EMR Sources

0+

Structured Variables

0%

Clinical-Closed Claims Overlap

0+

Abstracted Variables

0>

Biomarkers

0+

AI Models

What Data Trained Your AI?

Leading Innovators

On-Demand Data for
Accelerated Research

  • Comparative effectiveness in real-world populations compared to clinical trials
  • Study feasibility analyses
  • Patient population comparisons and analytics
  • Characteristics of patient journey and treatment sequencing over time
  • Adverse event detection and evaluation
  • Treatment patterns and analysis
  • Biomarker data impact on treatment selection and outcomes
  • External control arms
  • Clinical trial protocol development and optimization
  • Identification of undiagnosed and under-treated patient groups
  • Study feasibility analyses
  • Patient population comparisons and analytics
  • Characteristics of patient journey and treatment sequencing over time
  • Adverse event detection and evaluation
  • Treatment patterns and analysis
  • Biomarker data impact on treatment selection and outcomes
Data Products

AI-Enriched Real-World Data Products

Structured AI Insights for Large-Scale Analyses

RWD360™

RWD360 is a vast repository of pan tumor clinical data for broad analyses with the highest epidemiological relevance. Validated AI models enrich data for scale; claims linkage provides more complete insights into patient journeys.

All Tumors
High Coverage
AI-Enriched

Reasons for RWD360

Request Information
Compare Characteristics

Compare demographic characteristics based on different treatments.

See Treatment Sequencing

See how treatments and drug class exposures being sequenced in a cohort.

Combine Clinical Criteria

Understand which patients have a combination of clinical criteria, like ECOG and smoking status, and see the distribution of values for the cohort.

Customer Value for RWD360

Clinical Development Leaders

Rapidly generate insights into standard of care with on-demand access to thousands of data elements and accelerate innovation and drug development timelines.

Data Scientist & Trial Analytics Experts

Use advanced analytics and data science integrated with large real-world datasheets to work in new ways and optimize study design and execution.

Chief Development Officers

Centralize enterprise data needs with the ability to easily combine disparate datasets and shorten clinical development workflows with rich data and data science technologies.

By using RWD360 and eurekaHealth we are able to design our clinical studies in half the time of more traditional approaches.

—R&D Business Insights & Analytics Executive, Bristol-Myers Squibb

Study Design

Expertly Abstracted Data for Regulatory Purposes and Publication

Patient360

Patient360 is an off-the-shelf, deeply abstracted data product that removes the need for bespoke curation and allows direct insights into current standard of care on emerging disease and treatment dynamics.

Regulatory Grade
Deepest Industry Abstraction
On-Demand Datasets

Reasons for Patient360

Request Information
Identify Study Feasibility

Identify base rates of clinical characteristics, disease severity measures and treatment outcomes in real world treatment to inform the feasibility of using RWD as a comparator arm.

Post-Approval RWE

Conduct effectiveness outcomes studies in specific populations of interest and compare to clinical trials.

Track Safety

See adverse events experienced by real-world populations and compare to clinical trials.

Cost-of-Care Analyses

Link to closed claims for true calculations of healthcare utilization and cost-of-care.

Customer Value for Patient360

Clinical Development Leaders

Rapidly generate relevant insights into standard of care, develop novel research studies, and shorten drug development timelines.

Post-Approval/Epi-Safety Executives

Bring automation and data science to post-marketing analytics, comparative effectiveness studies, and risk surveillance.

Brand Managers

Assess and monitor treatment journeys and adherence patterns for strategic development and post-launch planning

Research Study

Performance of Proxy Measures Compared with Direct Observation of Progression-Free Survival

See results from findings presented at ISPOR 2020 and ASCO 2020 on the performance of proxy measures against directly-observed measures of PFS by using structured and unstructured information from ConcertAI’s Oncology Real-World Database.

See Research Study
Deep Clinico-Genomics Data

Genome360

Genome360 provides in-depth understanding of treatment profiles with data from NGS panels and structured and unstructured fields.

Full NGS Panel
Linked Genomic-Clinical
Deepest Industry Abstraction

Reasons for Genome360

Request Information
Biomarker Testing Results

See biomarker testing, results, and timing and understand trends and how they change over time.

Identify Patients by Gene Variants

Identify patients by any type of variant in a given gene, e.g. mutation, amplification, rearrangement, etc.

Assess Treatments and Outcomes

Assess how testing (and additionally, positivity) affects treatment selection and outcomes.

Customer Value for Genome360

Clinical Development Leaders

Rapidly generate relevant insights into standard of care, develop novel research studies, and shorten drug development timelines.

Post-Approval/Epi-Safety Executives

Bring automation and data science to post-marketing analytics, comparative effectiveness studies, and risk surveillance.

Brand Managers

Assess and monitor treatment journeys and adherence patterns for strategic development and post-launch planning.

Tailored Abstraction & Analytics

Custom Data Services for Specific Research Needs

Our team of HEOR and clinical oncology experts build unique data assets to support research questions that demand deeper insights.

Oncology and HEOR Expertise
Extensive Knowledge of RWD
Biostatistical Design and Execution
Regulatory Support and Publications

See Publications

Our scientific team regularly publishes with our clients based on research using custom data across a variety of therapeutic areas.

Reasons for ConcertAI Custom Data

Request Information
Precise Patient Journeys

Create bespoke datasets to explore the real-world treatment landscape

Depth of Information

Customize datasets for granular insights into specific outcomes and endpoints

Longitudinal Datasets

Commission datasets to function as EMR registries